Our study findings indicate that a vast majority of rheumatologists adhere to these recommendations, with only a small percentage suggesting biologic therapy for nr-axSpA patients in the absence of clinical or objective signs of inflammation, such as elevated CRP or sacroiliitis on MRI. Here, CRP is linked to Sacroiliac arthritis.